Trial intelligence / Profile preview

Neodolpasse after total hip arthroplasty

2004-002724-17Phase 3Completed

Sponsor
Fresenius Kabi
Start
Mar 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of Metocarbamol + paracetamol in postoperative pain (2 arms), sponsored by Fresenius Kabi. Primary endpoint: Morphine demand during first 24 hours postoperatively. Started Mar 2005; status: completed.

02

Drugs

Metocarbamol + paracetamol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2004-002724-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-002724-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call